Outlook in 2012

Filter By:

Article Type
Year
  • Preventing mosquitoes from transmitting the malaria parasite is a crucial piece of the eradication puzzle.

    • Lauren Gravitz
    Outlook
  • Even a cure is not preventing deaths from malaria in Uganda. Poor education and limited access to healthcare are among the reasons why.

    • Amy Maxmen
    Outlook
  • Despite some outstanding drug-development successes, the mouse version of multiple sclerosis has been worryingly unreliable at screening human treatments.

    • Jocelyn Rice
    Outlook
  • Population and genetic studies are confirming the link between multiple sclerosis and vitamin D, says Richard Ransohoff.

    • Richard M. Ransohoff
    Outlook
  • Most new treatments for multiple sclerosis are for patients with the relapsing–remitting form of the disease. Those with the more advanced, progressive type are being left behind.

    • Courtney Humphries
    Outlook
  • Technologies that better reveal the insidious progression of multiple sclerosis could aid the search for treatments.

    • Cynthia Graber
    Outlook
  • Researchers have plenty of theories about what might cause multiple sclerosis. But for now, the factor that triggers the disease remains elusive.

    • Lauren Gravitz
    Outlook
  • More than 100 variations in the genome have been linked to multiple sclerosis. Researchers are now trying to find the overlap with other auto-immune conditions, and understand how environmental factors interact with genes to trigger disease.

    • Virginia Hughes
    Outlook
  • A slew of new data suggests that it is time to rethink and reclassify autoimmune disease, says David A. Hafler.

    • David A. Hafler
    Outlook
  • Worms? Stents? Bee stings? Patients with multiple sclerosis who exhaust conventional therapies are turning in desperation to unproven approaches.

    • Jennifer Berglund
    Outlook
  • Researchers are still a long way from using stem cells to halt the decline caused by multiple sclerosis and to restore patients' health. But they are following some promising trails.

    • Michael Eisenstein
    Outlook
  • For decades, drugs have barely managed to slow the progression of multiple sclerosis. Therapies are now emerging that may even help to reverse the disease — but are they worth the risk?

    • Duncan Graham-Rowe
    Outlook
  • Graphene is phenomenally strong, thin, flexible, transparent and conductive — and applications beckon.

    • Neil Savage
    Outlook
    • Herb Brody
    Outlook
  • Transparency across the spectrum combined with electronic prowess makes graphene an ideal photonic material.

    • Neil Savage
    Outlook
  • Exploring graphene's chemical properties reveals a world of potential away from the purely two-dimensional, says Rodney Ruoff.

    • Rodney Ruoff
    Outlook
  • Flecks of graphene are easy to make. But producing sheets of pristine, electronics-quality material is another matter.

    • Richard Van Noorden
    Outlook